ProfileGDS4718 / 215303_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 16% 61% 12% 10% 14% 8% 13% 28% 9% 14% 20% 7% 4% 7% 23% 16% 8% 2% 8% 14% 22% 19% 18% 12% 7% 16% 14% 11% 10% 7% 11% 19% 12% 8% 6% 7% 27% 13% 70% 12% 7% 13% 7% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9791615
GSM549102patient 115, normal, homogenized [OPG study]3.9967316
GSM549104patient 119, normal, homogenized [OPG study]6.2323161
GSM549108patient 138, normal, homogenized [OPG study]3.8762912
GSM549119patient 077, normal, homogenized [OPG study]3.7793210
GSM549133patient 032, cancer, homogenized [OPG study]3.8804614
GSM549139patient 042, cancer, homogenized [OPG study]3.702998
GSM549099patient 107, normal, homogenized [OPG study]3.9112713
GSM549109patient 139, normal, homogenized [OPG study]4.4762128
GSM549110patient 046, normal, homogenized [OPG study]3.750459
GSM549114patient 063, normal, homogenized [OPG study]3.9161314
GSM549122patient 082, normal, homogenized [OPG study]4.1697820
GSM549134patient 033, cancer, homogenized [OPG study]3.655987
GSM549136patient 036, cancer, homogenized [OPG study]3.500434
GSM549140patient 044, cancer, homogenized [OPG study]3.653147
GSM549111patient 047, normal, homogenized [OPG study]4.2205623
GSM549113patient 057, normal, homogenized [OPG study]3.965816
GSM549132patient 031, cancer, homogenized [OPG study]3.710178
GSM549137patient 038, cancer, homogenized [OPG study]3.445422
GSM549142patient 047, cancer, homogenized [OPG study]3.735018
GSM549100patient 110, normal, homogenized [OPG study]3.9155714
GSM549107patient 135, normal, homogenized [OPG study]4.1901422
GSM549115patient 068, normal, homogenized [OPG study]4.0542619
GSM549116patient 072, normal, homogenized [OPG study]4.0382718
GSM549120patient 078, normal, homogenized [OPG study]3.8334212
GSM549131patient 030, cancer, homogenized [OPG study]3.637477
GSM549118patient 074, normal, homogenized [OPG study]4.0153616
GSM549129patient 027, cancer, homogenized [OPG study]3.9325914
GSM549123patient 088, normal, homogenized [OPG study]3.8393711
GSM549124patient 006, cancer, homogenized [OPG study]3.8096310
GSM549126patient 015, cancer, homogenized [OPG study]3.658617
GSM549128patient 025, cancer, homogenized [OPG study]3.7900611
GSM549103patient 117, normal, homogenized [OPG study]4.1522219
GSM549117patient 073, normal, homogenized [OPG study]3.8541912
GSM549138patient 041, cancer, homogenized [OPG study]3.700918
GSM549141patient 045, cancer, homogenized [OPG study]3.595616
GSM549130patient 028, cancer, homogenized [OPG study]3.682037
GSM549101patient 111, normal, homogenized [OPG study]4.4400527
GSM549105patient 128, normal, homogenized [OPG study]3.9065713
GSM549106patient 134, normal, homogenized [OPG study]6.9781970
GSM549112patient 048, normal, homogenized [OPG study]3.8521812
GSM549125patient 011, cancer, homogenized [OPG study]3.681587
GSM549127patient 024, cancer, homogenized [OPG study]3.8480313
GSM549135patient 035, cancer, homogenized [OPG study]3.638877